The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.
Also: German startup Wellster Healthtech brings its Series B raise to $60M, Faeth Therapeutics scoops up $20 million and Yuvo Health announces a $7.3 million seed round.
The male and female hormone tests are the first product in the company's Kind at Home consumer products division.
